- Home
- OST vs ALLR Comparison
OST vs ALLR Comparison
Compare OST & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OST
- ALLR
- Stock Information
- Founded
- OST 2010
- ALLR 2004
- Country
- OST China
- ALLR United States
- Employees
- OST N/A
- ALLR N/A
- Industry
- OST Industrial Machinery/Components
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- OST Technology
- ALLR Health Care
- Exchange
- OST Nasdaq
- ALLR Nasdaq
- Market Cap
- OST 15.7M
- ALLR 15.8M
- IPO Year
- OST 2022
- ALLR N/A
- Fundamental
- Price
- OST $2.02
- ALLR $0.90
- Analyst Decision
- OST
- ALLR Strong Buy
- Analyst Count
- OST 0
- ALLR 1
- Target Price
- OST N/A
- ALLR $9.00
- AVG Volume (30 Days)
- OST 384.9K
- ALLR 489.1K
- Earning Date
- OST 08-25-2025
- ALLR 08-15-2025
- Dividend Yield
- OST N/A
- ALLR N/A
- EPS Growth
- OST N/A
- ALLR N/A
- EPS
- OST N/A
- ALLR N/A
- Revenue
- OST $38,333,251.00
- ALLR N/A
- Revenue This Year
- OST N/A
- ALLR N/A
- Revenue Next Year
- OST N/A
- ALLR N/A
- P/E Ratio
- OST N/A
- ALLR N/A
- Revenue Growth
- OST 0.34
- ALLR N/A
- 52 Week Low
- OST $1.35
- ALLR $0.61
- 52 Week High
- OST $235.00
- ALLR $6.00
- Technical
- Relative Strength Index (RSI)
- OST 26.64
- ALLR 44.95
- Support Level
- OST $1.35
- ALLR $0.93
- Resistance Level
- OST $2.59
- ALLR $1.01
- Average True Range (ATR)
- OST 0.34
- ALLR 0.05
- MACD
- OST 3.48
- ALLR -0.01
- Stochastic Oscillator
- OST 66.67
- ALLR 14.00
About OST Ostin Technology Group Co. Ltd.
Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.